• Facebook
  • Twitter
  • LinkedIn
  • YouTube
Treeway
  • Home
  • R &D
  • Investors
  • Partners
  • Our Team
    • Executive Team
    • Scientific Advisory board
  • FAQ
  • Career
  • Contact
Select Page

Prize4Life award goes to Bernard Muller and Robbert Jan Stuit

by newtreeway | Dec 11, 2017

We are extremely proud on winning The Shay Rishoni Patient Impact Award. This award recognizes and rewards ALS/MND patients whose activities have made significant and outstanding contributions to ALS/MND research and drug discovery efforts. The award aims to...

Treeway mentioned in the latest issue of Health~Holland

by newtreeway | Dec 1, 2017

We are proud to be mentioned in the latest issue of Health~Holland about our world wide fight against ALS. Read this interesting article and many more in the latest issue about Life Sciences &...

Recent Posts

  • Rare Disease Symposium April 18th
  • Press Release: Treeway Announces Promising Data from Phase I Clinical Trial of Lead Program TW001 for ALS
  • Australian Motor Neurone Disease Symposium
  • ALS SYMPOSIUM: SAMEN TEGEN ALS. SAMEN VOOR DE PATIËNT
  • Prize4Life award goes to Bernard Muller and Robbert Jan Stuit

Archives

  • April 2019
  • May 2018
  • March 2018
  • December 2017

About Comany

Treeway is a clinical-stage biotechnology company with a mission to develop therapies to cure ALS. It was founded in 2012 by two ALS patients, Bernard Muller and Robbert Jan Stuit. Treeway aims to develop drugs that first delay disease progression, followed by therapies that halt or control the disease finally leading to a breakthrough therapy to cure ALS. Currently, Treeway has established a pipeline consisting of two drug therapies, TW001 and TW002, which are in development and is assessing several research lines to validate drugable targets.

News

  • Rare Disease Symposium April 18th April 10, 2019
  • Press Release: Treeway Announces Promising Data from Phase I Clinical Trial of Lead Program TW001 for ALS May 29, 2018
  • Australian Motor Neurone Disease Symposium March 21, 2018
  • ALS SYMPOSIUM: SAMEN TEGEN ALS. SAMEN VOOR DE PATIËNT March 15, 2018
  • Prize4Life award goes to Bernard Muller and Robbert Jan Stuit December 11, 2017

Treeway Twitter

Treeway@treewaytherapy·
31 May 2018

The Treeway Climbers will climb Mont Ventoux today for TOUR DU ALS! Help to raise more money to find a cure for ALS, donate to our team: https://www.tourduals.nl/team/treeway-climbers/doneren

Treeway@treewaytherapy·
29 May 2018

Treeway Announces Promising Data from Phase I Clinical Trial of Lead Program TW001 for ALS | Business Wire https://www.businesswire.com/news/home/20180529005493/en/Treeway-Announces-Promising-Data-Phase-Clinical-Trial#.Ww0gFp7hbLA.twitter

Treeway@treewaytherapy·
23 May 2018

Monday, the Treeway Runners participated in the ALS Lenteloop. A total of € 175.000,- was collected and will be used for ALS research!
Have you forgotten to sponsor our Treeway Runners? Next week, the Treeway Climbers will participate in Tour du ALS! https://lnkd.in/gcKKMGK

COPYRIGHT 2015, TREEWAY | T: +31 88 8733 929 E: INFO@TREEWAY.NL